Full Course Description
Fall Prevention Challenges: Real Solutions to Reduce Falls, Prevent Injuries and Limit Liability: Module 1
- Which fall prevention interventions are effective - and which are not?
- Tips to effectively manage your high risk & challenging patients
- The must-have tools for an effective multidisciplinary fall prevention program
- Identify risk: The latest guidelines for fall risk assessments
- New technology available to prevent falls and limit injury
- Comprehensive patient evaluations following a fall
Falls frequently result in significant adverse effects not only to patients but also to families and institutions. The far-reaching effects of falls make fall prevention an important topic for all healthcare providers. Falls are associated with increased morbidity and mortality and are frequently a source of litigation and insurance claim denial. The impact of falls is extensive from psychologically to financially. The complex multifactorial causes of falls, such as cognitive disorders, gait impairment and environmental factors, make fall prevention a challenge; however, there are evidence-based interventions available to mitigate the risks for even the most challenging situations.
Healthcare professionals are increasingly aware of the importance of fall data, adverse effects from falls and limited staffing resources to provide 1:1 supervision to prevent falls. This seminar will provide realistic, efficient, and effective solutions to address falls. Learn best practice guidelines, evidenced-based interventions and prevention strategies, as well as how to apply this knowledge to your practice setting. This seminar will provide a hands-on, logical step-by-step approach to develop effective fall prevention plans to reduce falls, prevent injuries and limit liability. Join me for this comprehensive and dynamic seminar to explore your challenges and develop solutions for your struggles with falls.
Program Information
Outline
How to Prevent Falls Before They Occur
- Who is likely to fall?
- Which risk factors can we modify?
- Precipitating causes - what to watch for
- Institutional barriers - avoiding 1:1s
- Important implications of co-morbidities
- The benefits of vitamin D
Fall Risk Assessment
- Current guidelines
- Who should we screen?
- Multi-factorial causes of falls
- Recommended fall risk assessments
Fall Prevention Strategies
- What works and what does not
- Addressing alarm fatigue
- Avoiding 1:1s
- Effective evidence-based interventions
- Education & assistive devices
Putting Together a Successful Fall Prevention Program
- Patient-specific interventions
- Developing a multidisciplinary program: Roles & responsibilities
- Fall rounds
Patient Evaluation
- History
- Physical exam
- Evaluation tools (POMA tool, Get up and go test, Functional reach test, Berg balance test, Short physical performance battery)
- Diagnostic tests
- Review of Gait Disorders (video)
What to do When a Patient Falls: Hands-On Evaluation
- Assess need for immediate medical care
- Evaluate for acute illness/preceding factors
- Communication with caregivers
- Common injuries
- Goals of care
Difficult Situations
- Frequent fallers - when injury prevention is your goal!
- Anticoagulation risks
- Prolonged time on floor
- What to do when fractures occur
- Head trauma management
Preventing Risk and Limiting Liability
- Home safety evaluations
- Communication and documentation
- Quality improvement opportunities
- High-risk scenarios: Case studies
- Addressing family concerns with falls
- Managing poor outcomes
Fall Prevention Plan Development
- Apply what we have learned
- Solutions for your biggest challenges!
Objectives
- Evaluate precipitating causes for falls so that preventative measures can be in place.
- Formulate a comprehensive evaluation for high fall risk patients.
- Analyze medications that are known to contribute in various ways to fall risks.
- Assess the risk for adverse patient outcome and need for urgent intervention.
- Determine the tools necessary for a multidisciplinary fall prevention program.
- Select patient-specific fall prevention interventions for a successful fall prevention plan.
- Evaluate the impact of common gait disorders on fall risk.
Target Audience
Nurses, Nursing Home Administrators, Occupational Therapists & Occupational Therapy Assistants, Physical Therapists/Physical Therapist Assistants, and other Healthcare Professionals
Copyright :
11/16/2016
Fall Prevention Challenges: Real Solutions to Reduce Falls, Prevent Injuries and Limit Liability: Module 2
Copyright :
11/16/2016
Fall Prevention Challenges: Real Solutions to Reduce Falls, Prevent Injuries and Limit Liability: Module 3
Copyright :
11/16/2016
Infection Control Challenges: Real Risks for Patients and Staff: Module 1
- EBOLA: What’s New, What’s True & What’s Next
- CRE – The new “Nightmare Bug”
- Serogroup B Vaccine – Meningococcal Disease a Thing of the Past
- Eradicate HIV
- New Testing & Treatment for TB
- New Reporting Requirements for the National Healthcare Safety Network
- Updates for Healthcare-Associated Infections
Open any newspaper or watch the daily news and you will find the next infectious disease scare. Infectious diseases have been called the terrorists of the natural world. As a healthcare provider you play a critical role in preventing the spread of infection.
Patients and families depend on you to provide them with the most up-to-date information and the best possible care. Controlling infectious disease is one of the most fundamentally important aspects of healthcare. Join nationally-recognized expert, author and epidemiologist, William “Barry” Inman, for this cutting-edge seminar.
Barry regularly works with the CDC and will share his first-hand knowledge of infectious disease, prevention strategies, and the newest treatment break-throughs. Barry will teach you essential strategies to protect patients and staff from resistant microorganisms, reemerging vaccine-preventable diseases, and new infectious threats. You will leave this seminar knowing proper precautions, disease management and the new required reporting guidelines.
Program Information
Outline
National Healthcare Safety Network
- New requirements from CMS
- Health-care Associated Infections what to report to the CDC
Compendium Strategies: Critical Updates
- Catheter-Associated Urinary Tract Infections
- Surgical Site Infections
- Ventilator Associated Pneumonias
- Central-Line Associated Bloodstream Infections
- Influenza Outbreaks in Healthcare
CDC, APIC, SHEA, IDSA Guidelines to Control Multi-Drug Resistant Organisms
- CRE: Carbapenem-Resistant Enterobacteriaceae
- The Nightmare Bug
- “Very” Resistant-Dangerous Klebisella and E. Coli
- Death rate of 50-60%
- C Diff: Clostridium Difficule
- Epidemiology
- New Treatments-cure 90%
- MRSA: Methicillin-Resistant Staphlococcus Aureus
- Community or Healthcare Associated
- Decolonization of MRSA
- VRE: Vancomycin Resistant Enterococcus
- Daptomycin Resistant Enterococcus
- ESBL: Extended Spectrum Beta-Lactamase Organisms
- Resistant Klebisella and E. Coli
EBOLA: What’s New, What’s True & What’s Next
- Probable Reservoir & Epizootic Cycle
- Bats
- Non-Human Primates
- Duikers
- Prior Outbreaks of Ebola in Africa
- Sudan (1976 & 1979 & 2005)
- Kikwit, Congo (1995)
- Gabon (1994-1996)
- Uganda (2000-2001 & 2007-2008)
- DRC (2007)
- Symptoms of Ebola
- Fever
- Myalgia
- Malaise
- Vomiting/Diarrhea
- Abdominal Pain
- Unexplained Hemorrhage
- Transmission of Ebola
- Bodily Fluids
- Cultural Rituals
- Possible Treatments for Ebola
- Supportive
- Mono-clonal Antibodies
- Appropriate Infection Control Protocols
- PPEs
- During Aerosol-Generating Procedures
- Hand-washing and Disinfectants
- Appropriate laboratory tests
- Protocol for Testing for Ebola
- Appropriate Risks
- CDC (Centers for Disease Control)
Emerging Infectious Diseases: Exotic to the Common
- Meningococcal Disease
- Bacterial, Fungal & Viral Meningitis
- New Vaccines for Serogroup B
- Could be a disease of the past
- Dengue Fever and Chikungunya
- Tickborne Diseases
- Lyme
- Ehrichioses
- Babesiosis
- Rocky Mountain Spotted Fever
Managing Foodborne Illnesses
- E. Coli O157-H7
- Salmonella
- Listeria
- Campylobacter
- Vibrio
- Norovirus
Vaccine Preventable Diseases are Back!
- Pertussis (Whooping cough)
- Measles
- Controlling Outbreaks
Influenza Information
- Current Vaccine
- Treatments
- Prophylaxis
- Infection Control Protocols
- Seasonal vs Pandemics (H1N1)
Pneumococcal Disease
- New Vaccine for Adults
- New Protocols
- PPSV-23 & PCV-13
Updates & New Protocols for Bloodborne Pathogens
- Hepatitis B:
- Protocols for Immunizations
- Healthcare Personnel
- Children-Adolescents
- Diabetics
- Approved Treatments for Chronic Hepatitis B
- Outbreaks of Hepatitis B and C in Healthcare
- Hepatitis C:
- Risk Groups and Factors
- New Treatment
- One pill for 12 weeks
- 95-100% Cure Rate
- HIV/AIDS:
- “Now a Confirmed Cured Patient”
- The Science Behind the Cure
- New Treatment: One Pill a Day
- Prophylaxis for High Risk Groups
- The Strategy to Eradicate HIV-AIDS
- Tuberculosis:
- Blood Test vs Skin Testing
- IGRA (Interferon Gamma Release Assays)
- New Treatment Protocols
- New Prophylaxis Regimen
- Three Months vs Nine Months
- Infection Control Protocols for TB
Objectives
- Plan strategies to reduce and eliminate catheter-associated urinary tract infections, surgical site infections, ventilator associated and non-ventilator-associated pneumonias and central-line-associated bloodstream infections.
- Assess best practices for treatment and control of multi-drug resistant microorganisms, including MRSA, Clostridium difficile, VRE, ESBL and CRE.
- Evaluate the newest vaccine recommendations for healthcare workers and children.
- Distinguish between mosquito-borne illnesses of Dengue, Chikungunya, and Zika, which may be a threat to the United States.
- Assess the latest treatments available for HIV/AIDS, as well as pre-exposure prophylaxis.
- Determine the medications available that "cure" Hepatitis C.
- Evaluate the current recommendations to control and treat tuberculosis.
Target Audience
Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, Respiratory Therapists
Copyright :
10/13/2016
Infection Control Challenges: Real Risks for Patients and Staff: Module 2
- EBOLA: What’s New, What’s True & What’s Next
- CRE – The new “Nightmare Bug”
- Serogroup B Vaccine – Meningococcal Disease a Thing of the Past
- Eradicate HIV
- New Testing & Treatment for TB
- New Reporting Requirements for the National Healthcare Safety Network
- Updates for Healthcare-Associated Infections
Open any newspaper or watch the daily news and you will find the next infectious disease scare. Infectious diseases have been called the terrorists of the natural world. As a healthcare provider you play a critical role in preventing the spread of infection.
Patients and families depend on you to provide them with the most up-to-date information and the best possible care. Controlling infectious disease is one of the most fundamentally important aspects of healthcare. Join nationally-recognized expert, author and epidemiologist, William “Barry” Inman, for this cutting-edge seminar.
Barry regularly works with the CDC and will share his first-hand knowledge of infectious disease, prevention strategies, and the newest treatment break-throughs. Barry will teach you essential strategies to protect patients and staff from resistant microorganisms, reemerging vaccine-preventable diseases, and new infectious threats. You will leave this seminar knowing proper precautions, disease management and the new required reporting guidelines.
OUTLINE
National Healthcare Safety Network
- New requirements from CMS
- Health-care Associated Infections what to report to the CDC
Compendium Strategies: Critical Updates
- Catheter-Associated Urinary Tract Infections
- Surgical Site Infections
- Ventilator Associated Pneumonias
- Central-Line Associated Bloodstream Infections
- Influenza Outbreaks in Healthcare
CDC, APIC, SHEA, IDSA Guidelines to Control Multi-Drug Resistant Organisms
- CRE: Carbapenem-Resistant Enterobacteriaceae
- The Nightmare Bug
- “Very” Resistant-Dangerous Klebisella and E. Coli
- Death rate of 50-60%
- C Diff: Clostridium Difficule
- Epidemiology
- New Treatments-cure 90%
- MRSA: Methicillin-Resistant Staphlococcus Aureus
- Community or Healthcare Associated
- Decolonization of MRSA
- VRE: Vancomycin Resistant Enterococcus
- Daptomycin Resistant Enterococcus
- ESBL: Extended Spectrum Beta-Lactamase Organisms
- Resistant Klebisella and E. Coli
EBOLA: What’s New, What’s True & What’s Next
- Probable Reservoir & Epizootic Cycle
- Bats
- Non-Human Primates
- Duikers
- Prior Outbreaks of Ebola in Africa
- Sudan (1976 & 1979 & 2005)
- Kikwit, Congo (1995)
- Gabon (1994-1996)
- Uganda (2000-2001 & 2007-2008)
- DRC (2007)
- Symptoms of Ebola
- Fever
- Myalgia
- Malaise
- Vomiting/Diarrhea
- Abdominal Pain
- Unexplained Hemorrhage
- Transmission of Ebola
- Bodily Fluids
- Cultural Rituals
- Possible Treatments for Ebola
- Supportive
- Mono-clonal Antibodies
- Appropriate Infection Control Protocols
- PPEs
- During Aerosol-Generating Procedures
- Hand-washing and Disinfectants
- Appropriate laboratory tests
- Protocol for Testing for Ebola
- Appropriate Risks
- CDC (Centers for Disease Control)
Emerging Infectious Diseases: Exotic to the Common
- Meningococcal Disease
- Bacterial, Fungal & Viral Meningitis
- New Vaccines for Serogroup B
- Could be a disease of the past
- Dengue Fever and Chikungunya
- Tickborne Diseases
- Lyme
- Ehrichioses
- Babesiosis
- Rocky Mountain Spotted Fever
Managing Foodborne Illnesses
- E. Coli O157-H7
- Salmonella
- Listeria
- Campylobacter
- Vibrio
- Norovirus
Vaccine Preventable Diseases are Back!
- Pertussis (Whooping cough)
- Measles
- Controlling Outbreaks
Influenza Information
- Current Vaccine
- Treatments
- Prophylaxis
- Infection Control Protocols
- Seasonal vs Pandemics (H1N1)
Pneumococcal Disease
- New Vaccine for Adults
- New Protocols
- PPSV-23 & PCV-13
Updates & New Protocols for Bloodborne Pathogens
- Hepatitis B:
- Protocols for Immunizations
- Healthcare Personnel
- Children-Adolescents
- Diabetics
- Approved Treatments for Chronic Hepatitis B
- Outbreaks of Hepatitis B and C in Healthcare
- Hepatitis C:
- Risk Groups and Factors
- New Treatment
- One pill for 12 weeks
- 95-100% Cure Rate
- HIV/AIDS:
- “Now a Confirmed Cured Patient”
- The Science Behind the Cure
- New Treatment: One Pill a Day
- Prophylaxis for High Risk Groups
- The Strategy to Eradicate HIV-AIDS
- Tuberculosis:
- Blood Test vs Skin Testing
- IGRA (Interferon Gamma Release Assays)
- New Treatment Protocols
- New Prophylaxis Regimen
- Three Months vs Nine Months
- Infection Control Protocols for TB
OBJECTIVES
- Summarize the key components of an effective Infection control program.
- Interpret the Centers for Disease Control (CDC), Association of Preventionist in Infection Control (APIC), Society of Hospital Epidemiologist (SHEA) and the Infectious Disease Society Association (IDSA) guidelines to control-prevent Health-care Associated Infections such as Influenza, Norovirus, Ventilator-Associated Pneumonia, Catheter Associated Blood-stream infections, catheter associated urinary tract infections and Surgical site infections.
- Identify typical symptoms of Ebola.
- Explain transmission routes and the potential treatments for Ebola.
- Examine appropriate surveillance protocols to detect Health-care associated infections.
- Describe the extent and control of drug resistant microorganisms such as MRSA, VRE, ESBL, CRE, and C. difficule.
- Specify the latest vaccine available for healthcare personnel, children-adolescents, and adults.
- Summarize recent standards by OSHA regarding post exposure prophylaxis and the use of rapid HIV testing methodologies.
- Discuss appropriate management-control of Influenza for patients, and healthcare facilities.
- Differentiate between seasonal and pandemic influenza.
- Discuss and classify the treatment and symptoms of food-borne illness.
- Discuss to treatment protocols of bloodborne pathogens.
To order the book, Infection Control: Emerging Infectious Diseases, please visit our product store.
To order the book, Laboratory Tests Made Easy, please visit our product store.
Target Audience
Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, Respiratory Therapists
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
Program Information
Objectives
- Plan strategies to reduce and eliminate catheter-associated urinary tract infections, surgical site infections, ventilator associated and non-ventilator-associated pneumonias and central-line-associated bloodstream infections.
- Assess best practices for treatment and control of multi-drug resistant microorganisms, including MRSA, Clostridium difficile, VRE, ESBL and CRE.
- Evaluate the newest vaccine recommendations for healthcare workers and children.
- Distinguish between mosquito-borne illnesses of Dengue, Chikungunya, and Zika, which may be a threat to the United States.
- Assess the latest treatments available for HIV/AIDS, as well as pre-exposure prophylaxis.
- Determine the medications available that "cure" Hepatitis C.
- Evaluate the current recommendations to control and treat tuberculosis.
Copyright :
10/13/2016
Infection Control Challenges: Real Risks for Patients and Staff: Module 3
- EBOLA: What’s New, What’s True & What’s Next
- CRE – The new “Nightmare Bug”
- Serogroup B Vaccine – Meningococcal Disease a Thing of the Past
- Eradicate HIV
- New Testing & Treatment for TB
- New Reporting Requirements for the National Healthcare Safety Network
- Updates for Healthcare-Associated Infections
Open any newspaper or watch the daily news and you will find the next infectious disease scare. Infectious diseases have been called the terrorists of the natural world. As a healthcare provider you play a critical role in preventing the spread of infection.
Patients and families depend on you to provide them with the most up-to-date information and the best possible care. Controlling infectious disease is one of the most fundamentally important aspects of healthcare. Join nationally-recognized expert, author and epidemiologist, William “Barry” Inman, for this cutting-edge seminar.
Barry regularly works with the CDC and will share his first-hand knowledge of infectious disease, prevention strategies, and the newest treatment break-throughs. Barry will teach you essential strategies to protect patients and staff from resistant microorganisms, reemerging vaccine-preventable diseases, and new infectious threats. You will leave this seminar knowing proper precautions, disease management and the new required reporting guidelines.
OUTLINE
National Healthcare Safety Network
- New requirements from CMS
- Health-care Associated Infections what to report to the CDC
Compendium Strategies: Critical Updates
- Catheter-Associated Urinary Tract Infections
- Surgical Site Infections
- Ventilator Associated Pneumonias
- Central-Line Associated Bloodstream Infections
- Influenza Outbreaks in Healthcare
CDC, APIC, SHEA, IDSA Guidelines to Control Multi-Drug Resistant Organisms
- CRE: Carbapenem-Resistant Enterobacteriaceae
- The Nightmare Bug
- “Very” Resistant-Dangerous Klebisella and E. Coli
- Death rate of 50-60%
- C Diff: Clostridium Difficule
- Epidemiology
- New Treatments-cure 90%
- MRSA: Methicillin-Resistant Staphlococcus Aureus
- Community or Healthcare Associated
- Decolonization of MRSA
- VRE: Vancomycin Resistant Enterococcus
- Daptomycin Resistant Enterococcus
- ESBL: Extended Spectrum Beta-Lactamase Organisms
- Resistant Klebisella and E. Coli
EBOLA: What’s New, What’s True & What’s Next
- Probable Reservoir & Epizootic Cycle
- Bats
- Non-Human Primates
- Duikers
- Prior Outbreaks of Ebola in Africa
- Sudan (1976 & 1979 & 2005)
- Kikwit, Congo (1995)
- Gabon (1994-1996)
- Uganda (2000-2001 & 2007-2008)
- DRC (2007)
- Symptoms of Ebola
- Fever
- Myalgia
- Malaise
- Vomiting/Diarrhea
- Abdominal Pain
- Unexplained Hemorrhage
- Transmission of Ebola
- Bodily Fluids
- Cultural Rituals
- Possible Treatments for Ebola
- Supportive
- Mono-clonal Antibodies
- Appropriate Infection Control Protocols
- PPEs
- During Aerosol-Generating Procedures
- Hand-washing and Disinfectants
- Appropriate laboratory tests
- Protocol for Testing for Ebola
- Appropriate Risks
- CDC (Centers for Disease Control)
Emerging Infectious Diseases: Exotic to the Common
- Meningococcal Disease
- Bacterial, Fungal & Viral Meningitis
- New Vaccines for Serogroup B
- Could be a disease of the past
- Dengue Fever and Chikungunya
- Tickborne Diseases
- Lyme
- Ehrichioses
- Babesiosis
- Rocky Mountain Spotted Fever
Managing Foodborne Illnesses
- E. Coli O157-H7
- Salmonella
- Listeria
- Campylobacter
- Vibrio
- Norovirus
Vaccine Preventable Diseases are Back!
- Pertussis (Whooping cough)
- Measles
- Controlling Outbreaks
Influenza Information
- Current Vaccine
- Treatments
- Prophylaxis
- Infection Control Protocols
- Seasonal vs Pandemics (H1N1)
Pneumococcal Disease
- New Vaccine for Adults
- New Protocols
- PPSV-23 & PCV-13
Updates & New Protocols for Bloodborne Pathogens
- Hepatitis B:
- Protocols for Immunizations
- Healthcare Personnel
- Children-Adolescents
- Diabetics
- Approved Treatments for Chronic Hepatitis B
- Outbreaks of Hepatitis B and C in Healthcare
- Hepatitis C:
- Risk Groups and Factors
- New Treatment
- One pill for 12 weeks
- 95-100% Cure Rate
- HIV/AIDS:
- “Now a Confirmed Cured Patient”
- The Science Behind the Cure
- New Treatment: One Pill a Day
- Prophylaxis for High Risk Groups
- The Strategy to Eradicate HIV-AIDS
- Tuberculosis:
- Blood Test vs Skin Testing
- IGRA (Interferon Gamma Release Assays)
- New Treatment Protocols
- New Prophylaxis Regimen
- Three Months vs Nine Months
- Infection Control Protocols for TB
OBJECTIVES
- Summarize the key components of an effective Infection control program.
- Interpret the Centers for Disease Control (CDC), Association of Preventionist in Infection Control (APIC), Society of Hospital Epidemiologist (SHEA) and the Infectious Disease Society Association (IDSA) guidelines to control-prevent Health-care Associated Infections such as Influenza, Norovirus, Ventilator-Associated Pneumonia, Catheter Associated Blood-stream infections, catheter associated urinary tract infections and Surgical site infections.
- Identify typical symptoms of Ebola.
- Explain transmission routes and the potential treatments for Ebola.
- Examine appropriate surveillance protocols to detect Health-care associated infections.
- Describe the extent and control of drug resistant microorganisms such as MRSA, VRE, ESBL, CRE, and C. difficule.
- Specify the latest vaccine available for healthcare personnel, children-adolescents, and adults.
- Summarize recent standards by OSHA regarding post exposure prophylaxis and the use of rapid HIV testing methodologies.
- Discuss appropriate management-control of Influenza for patients, and healthcare facilities.
- Differentiate between seasonal and pandemic influenza.
- Discuss and classify the treatment and symptoms of food-borne illness.
- Discuss to treatment protocols of bloodborne pathogens.
To order the book, Infection Control: Emerging Infectious Diseases, please visit our product store.
To order the book, Laboratory Tests Made Easy, please visit our product store.
Target Audience
Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, Respiratory Therapists
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
Program Information
Objectives
- Plan strategies to reduce and eliminate catheter-associated urinary tract infections, surgical site infections, ventilator associated and non-ventilator-associated pneumonias and central-line-associated bloodstream infections.
- Assess best practices for treatment and control of multi-drug resistant microorganisms, including MRSA, Clostridium difficile, VRE, ESBL and CRE.
- Evaluate the newest vaccine recommendations for healthcare workers and children.
- Distinguish between mosquito-borne illnesses of Dengue, Chikungunya, and Zika, which may be a threat to the United States.
- Assess the latest treatments available for HIV/AIDS, as well as pre-exposure prophylaxis.
- Determine the medications available that "cure" Hepatitis C.
- Evaluate the current recommendations to control and treat tuberculosis.
Copyright :
10/13/2016